Premium
IMMUNOREACTIVE TRYPSIN, CHYMOTRYPSIN, AND PANCREATIC SECRETORY TRYPSIN INHIBITOR IN CORD BLOOD FROM INFANTS WITH CYSTIC FIBROSIS
Author(s) -
BORGSTRÖM ANDERS,
SVEGER TOMAS,
LINDBERG TOR,
KULLANDER STIG,
SVANBERG LARS
Publication year - 1981
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1981.tb05756.x
Subject(s) - cystic fibrosis , trypsin , medicine , chymotrypsin , cord blood , pancreatic disease , endocrinology , gastroenterology , enzyme , pancreas , biochemistry , biology
ABSTRACT. Borgström, A., Sveger, T., Lindberg, T., Kullander, S. and Svanberg, L. (Departments of Clinical Chemistry, Paediatrics and Obstetrics, University of Lund, Malmö General Hospital, Malmö, Sweden). Immunoreactive trypsin, chymotrypsin and pancreatic secretory trypsin inhibitor in cord blood from infants with cystic fibrosis. Acta Paediatr Scand, 70: 619,.–Immunoreactive trypsin, chymotrypsin, and pancreatic secretory trypsin inhibitor in cord blood were measured in six infants with cystic fibrosis and in ten control infants for each index child. These three pancreatic proteins were 2.5–6.7, 2.2–7.5, and 1.3–4.2 times higher, respectively, than the corresponding mean levels of the control infants.